![](/img/cover-not-exists.png)
PM2 IMPACT OF PHARMACOGENETICS ON THE COSTS OF MANAGING ADVERSE EVENTS WITH WARFARIN: A PROSPECTIVE ANALYSIS
DA Hughes, S Al-Zubiedi, A Hanson, A Jorgensen, M PirmohamedVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73081-3
File:
PDF, 116 KB
english, 2009